Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Protective effect of CCR5-Δ32 against HIV infection by the heterosexual mode of transmission in a Polish population.

Zwolińska K, Knysz B, Rybka K, Pazgan-Simon M, Gąsiorowski J, Sobczyński M, Gładysz A, Piasecki E.

AIDS Res Hum Retroviruses. 2013 Jan;29(1):54-60. doi: 10.1089/AID.2011.0362. Epub 2012 Oct 9.

PMID:
22957692
2.

[Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].

Wasik TJ, Smoleń J, Kruszyński P, Bratosiewicz-Wasik J, Beniowski M.

Wiad Lek. 2005;58(9-10):500-7. Polish.

PMID:
16529059
3.

Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.

Wang FS, Hong WG, Cao Y, Liu MX, Jin L, Hu LP, Wang Z, Feng TJ, Hou J, Zhang B, Shi M, Xu DP, Lei ZY, Wang B, Liu ZD, Ye JJ, Peng L, Qiu Y, Winkler C.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):124-30.

PMID:
12571520
4.
5.

Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.

Lockett SF, Alonso A, Wyld R, Martin MP, Robertson JR, Gore SM, Leen CL, Brettle RP, Yirrell DL, Carrington M, Brown AJ.

J Infect Dis. 1999 Sep;180(3):614-21.

PMID:
10438347
6.

Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection.

Mangano A, Kopka J, Batalla M, Bologna R, Sen L.

J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):52-7.

PMID:
10708056
7.

Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.

Tan XH, Zhang JY, Di CH, Hu AR, Yang L, Qu S, Zhao RL, Yang PR, Guo SX.

Infect Genet Evol. 2010 Mar;10(2):268-72. doi: 10.1016/j.meegid.2009.11.015. Epub 2009 Dec 1.

PMID:
19958843
8.

Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.

Ioannidis JP, Contopoulos-Ioannidis DG, Rosenberg PS, Goedert JJ, De Rossi A, Espanol T, Frenkel L, Mayaux MJ, Newell ML, Pahwa SG, Rousseau C, Scarlatti G, Sei S, Sen L, O'Brien TR; HIV Host Genetics International Meta-Analysis Group.

AIDS. 2003 Jul 25;17(11):1631-8.

PMID:
12853745
9.

Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage GR 3rd; HIV Network for Prevention Trials Vaccine Preparedness Protocol Team.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):472-81.

PMID:
11511825
10.

Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.

Mulherin SA, O'Brien TR, Ioannidis JP, Goedert JJ, Buchbinder SP, Coutinho RA, Jamieson BD, Meyer L, Michael NL, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Theodorou ID, Vlahov D, Rosenberg PS; International Meta-Analysis of HIV Host Genetics.

AIDS. 2003 Feb 14;17(3):377-87.

PMID:
12556692
11.

Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.

Reiche EM, Ehara Watanabe MA, Bonametti AM, Morimoto HK, Akira Morimoto A, Wiechmann SL, Matsuo T, Carvalho De Oliveira J, Vissoci Reiche F.

Int J Mol Med. 2008 Nov;22(5):669-75.

PMID:
18949389
12.

Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.

Salem AH, Farid E, Fadel R, Abu-Hijleh M, Almawi W, Han K, Batzer MA.

AIDS Res Hum Retroviruses. 2009 Oct;25(10):973-7. doi: 10.1089/aid.2009.0066.

PMID:
19803715
13.

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U.

Gastroenterology. 2002 Jun;122(7):1721-8.

PMID:
12055576
14.

Genetic variations in CC chemokine receptors and hypertension.

Zhang M, Ardlie K, Wacholder S, Welch R, Chanock S, O'Brien TR.

Am J Hypertens. 2006 Jan;19(1):67-72.

PMID:
16461193
15.

[Genetic polymorphism of human immunodeficiency virus coreceptor CCR5Delta32 and CCR2-64I alleles in Chinese Yi Ethnic group in Sichuan].

Deng XL, Hong KX, Chen JP, Ruan YH, Xu MY, Qin GM, Li K, Xing H, Shao YM.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Dec;25(12):1050-3. Chinese.

PMID:
15769362
16.

Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.

Apostolakis S, Baritaki S, Krambovitis E, Spandidos DA.

J Clin Virol. 2005 Dec;34(4):310-4.

PMID:
16286055
17.

Gene polymorphisms in CCR5, CCR2, SDF1 and RANTES among Chinese Han population with HIV-1 infection.

Li H, Liu TJ, Hong ZH.

Infect Genet Evol. 2014 Jun;24:99-104. doi: 10.1016/j.meegid.2014.03.009. Epub 2014 Mar 18.

PMID:
24650919
18.

Distribution of CCR2-64I and SDF1-3'A alleles and HIV status in 7 ethnic populations of Cameroon.

Ma L, Marmor M, Zhong P, Ewane L, Su B, Nyambi P.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):89-95.

PMID:
16123688
19.

Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.

Teixeira SL, Bastos FI, Hacker MA, Morgado MG.

Infect Genet Evol. 2009 Jul;9(4):638-42. doi: 10.1016/j.meegid.2009.03.007. Epub 2009 Apr 5.

PMID:
19460331
20.

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.

Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, O'Brien SJ.

Science. 1997 Aug 15;277(5328):959-65.

Supplemental Content

Support Center